Related Experiment Video
Updated: May 15, 2026

08:25
A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
Published on: June 10, 2025
Sequential histologic changes in the healing process in small bowel allografts treated for acute cellular rejection
L Liu1, R T Fischer, L Xu
1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Transplantation Proceedings
|December 27, 2012
Summary
Understanding the timeline of acute cellular rejection (ACR) resolution in small intestinal transplants is crucial. Histologic features like epithelial injury and lamina propria inflammation significantly decrease within one week of treatment.
Area of Science:
- Gastroenterology
- Transplant Surgery
- Pathology
Background:
- Acute cellular rejection (ACR) is a frequent complication following small intestinal transplantation.
- Assessing treatment response in ACR requires understanding the temporal resolution of biopsy findings.
- Pathologists need to differentiate between resolving and ongoing rejection in follow-up biopsies.
Purpose of the Study:
- To determine the sequence and timing of resolution for key histologic features of acute cellular rejection after treatment in small intestinal transplant recipients.
- To provide guidance for pathologists evaluating follow-up biopsies for ACR treatment efficacy.
Main Methods:
- Retrospective review of 16 small intestinal transplant cases with diagnosed ACR and subsequent biopsies.
- Evaluation of epithelial injury, lamina propria inflammation, and crypt apoptotic bodies in biopsies before and after treatment.
- Comparison with age-matched control biopsies.
Main Results:
- Epithelial injury (mucin depletion) resolved by 2 weeks post-treatment.
- Lamina propria inflammation significantly decreased by 1 week and normalized by 3 weeks.
- Apoptosis levels fell below the rejection threshold by 2 weeks and reached control levels by 3 weeks.
Conclusions:
- The resolution of histologic ACR features follows a predictable timeline after therapy.
- Reduced epithelial injury and lamina propria inflammation are evident within 1 week of treatment.
- Persistent findings may indicate ongoing rejection, aiding in patient management.

